B
BDSX
BIODESIX INC
23.26
-1.47-5.93%After Hours: 23.72 +0.47 +2.00%19:30 10/30 EDT
OPEN/PREV CLOSE21.30/21.49
TODAY RANGE19.07-21.30
VOL1.03K
MARKET CAP220.00M
52 WEEK RANGE5.26-31.97
AVG VOL (3M)105.12K
% TURNOVER1.50%
TURNOVER0
P/E (TTM)-6.2610
% RANGE10.39%
EPS(TTM)-3.1688
P/E(FORWARD)-7.4267
P/B22.89
BVPS0.8667
DIVIDEND--
P/S1.850
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP122.84M
SHARES OUTSTANDING11.09M
NEXT EARNINGS11/02-11/06
FREE FLOAT6.19M
LOT SIZE1
EX-DATE09/15/2025
News
Press Releases
Financial Reports
Profile
TipRanks·11h ago
Biodesix Announces Departure of Chief Commercial Officer
Seeking Alpha·10/29 19:12
Russell 2000 estimated to add 107 stocks in December rebalance - Stephens
NASDAQ·10/29 15:00
All You Need to Know About Biodesix (BDSX) Rating Upgrade to Buy
Benzinga·10/19 10:03
Biodesix Adds AI-Powered Imaging Test To Expand Lung Cancer Risk Screening
Dow Jones·10/13 16:08
Biodesix Is Maintained at Buy by TD Cowen
Benzinga·10/13 15:58
TD Cowen Maintains Buy on Biodesix, Raises Price Target to $40
TipRanks·10/13 12:35
Biodesix price target raised to $40 from $30 at TD Cowen
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.